国产成人精品高清久久_好姑娘影视在线观看高清_99久久久久久久久_欧美涩涩网_久久国产精品91_9色网站

美國 TGen  The Translational Genomics Research Institute  
翻譯基因組學研究院（TGen）是一個位于亞利桑那州鳳凰城的非盈利組織，致力于開展開創性的研究以改善生活。TGen的研究著重于幫助那些罹患癌癥、神經系統疾病及糖尿病的患者。TGen 在轉譯研究領域遙遙領先，其研究人員致力于揭示常見疾病和復雜疾病的基因成分。通過與科研和醫學界的通力合作，TGen 堅信可對轉譯過程的功效做出重大貢獻。

The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments.

Translational genomics research is a relatively new field employing innovative advances arising from the  and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.

For the first time in history, we now have the knowledge to unravel the genetic components of common and complex diseases. The increased understanding of  is shifting clinical practice from treatment based on symptoms to treatment based on the underlying causes of disease. Physicians will be prescribing drugs that are designed more intelligently, work more effectively, and have fewer toxic side effects.

The mapping of the human genome was only the first step. Researchers are now working to translate variations in human genes to discover the underlying cause of disease progression and resistance to therapy and why some individuals encounter debilitating diseases and others live healthy lives. Although all the puzzle pieces of our genetic make-up have been identified, scientists and clinicians now have the formidable task of interpreting how they fit together in order to apply the genome map to patient care.

TGen is on the cutting edge of  where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen's vision is of a world where an understanding of genomic variation can be rapidly translated to the diagnosis and treatment of disease in a manner tailored to individual patients.

TGen is dedicated to the next revolution in health care. With the patient at its helm, TGen is guided by three core principles: integrate, translate and accelerate.

Integrate
Discovering the differences and changes within the genome that translate into disease is a priority for TGen. To accomplish its mission, TGen successfully recruited cross-functional teams, including world-renowned engineers, geneticists, clinicians, biologists, and computational experts. have an intense desire to move their research into the clinical setting, and TGen has given them the opportunity to impact disease in a manner that had not been available to them before. As a result, TGen's combined excellence in genomic analysis, bioinformatics, and cancer drug development is unmatched throughout the industry.

To further genomic-based disease research, TGen also has established novel research programs. By implementing specific population studies, significant genomic findings can be expedited that will positively impact individuals with diabetes, autism, prostate and breast cancer, melanoma, and gastric cancer, to name a few. TGen's  are disease focused and supported by a strong base of core technology platforms that allows research to be done on a large scale and short timeframe. As such, results are high-volume and quickly generated.

Translate
At the core of TGen's translational research strategy is the development of "accelerators" to quickly move research discoveries into the clinic to benefit patients. While many other research institutes recognize the importance of such translational vehicles, TGen stands alone in making this the cornerstone of its strategy. TGen has established accelerators as vehicles to develop therapeutics, prognostics and diagnostics and to deliver research discoveries to patients as quickly as possible. Not only do these accelerators provide immediate benefits to patients, but the knowledge gained from these services continues to inform TGen's research and promote patient health. Progress in genomics moves incrementally, but the potential for accelerated success is much higher at TGen because we have built one of the strongest translational development teams in the world.

Accelerate
A hallmark of TGen is our belief in the strength and importance of collaborative partnerships. TGen has partnered with academia, government agencies, clinical, and corporate entities in Arizona and across the globe. Such relationships provide TGen unmatched access to expertise and technology to accelerate its research goals. Through collaborative efforts with clinical partners, links to the patient are established and benefits of TGen can be delivered to the bedside. Only by combining the experience of clinicians with the direct discoveries of the research scientists will the maximum benefit to the patient be achieved. The fusion of modern medicine with the power of translational research fuels the next wave of treatments for disease.

Supporting TGen
TGen is a non-profit research institute that relies on state and federal funding and the generous backing of businesses, foundations, and concerned individuals. All contributions assist in our research efforts, whether through the acquisition of needed equipment, access to essential clinical resources, or support and expansion of the research team.

We are eager to hear from anyone who is interested in how the revolutionary power of genomics can help in fighting disease. TGen's research program combined with scientific and clinical expertise is ready to move genomic discoveries to the clinic for the benefit and care of all.

For additional information on how you can help, please visit the  or e-mail us: